This bill, known as the Daughters of the American Revolution Membership Integrity Act, amends federal law to explicitly limit membership in the Daughters of the American Revolution to adult human females. It defines a female as someone who naturally possesses or would have the reproductive system capable of producing ova for fertilization, regardless of any congenital anomalies or medical disruptions. By adding this specific definition to the organization's governing code, the legislation clarifies the genealogical and biological requirements for joining the group. The change directly affects the organization's eligibility rules but does not alter its internal operations or funding.
The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release records of specific agreements between the federal government and major drug manufacturers starting in 2025. These agreements must include provisions such as offering lower drug prices based on international rates, providing discounts through government platforms like TrumpRx, or receiving special exemptions from import duties and regulatory reviews. While the bill mandates that most documents be made available in a searchable format, it allows the government to withhold only specific confidential pricing details if legally required by foreign laws or court orders, provided a justification is published. Additionally, the law directs the Congressional Budget Office and the Government Accountability Office to analyze the economic and budgetary impacts of these deals, including effects on Medicare, Medicaid, and drug competition.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
The Medicare Access to Rural Anesthesiology Act changes how Medicare pays for anesthesia services at specific small rural hospitals and critical access hospitals. To qualify for these changes, a hospital must be located in a rural area, have fewer than 800 surgeries requiring anesthesia, and employ or contract with no more than one full-time anesthesiologist who agrees not to bill Medicare separately for those services. Once a hospital meets these criteria, anesthesia care provided by an anesthesiologist there will be paid based on the hospital's actual costs rather than a fixed fee, and it will be classified as part of the hospital's inpatient services instead of a separate billable service. The law also requires the Department of Health and Human Services to update its regulations to reflect these new payment rules.
The Essential Caregivers Act of 2026 requires nursing homes, long-term care hospitals, rehabilitation facilities, and intermediate care facilities to allow two chosen family members or friends to visit residents during times when regular visitation is suspended. These essential caregivers must agree to follow the facility's existing safety and infection control rules, which are no more restrictive than those applied to staff. While facilities can limit access for the first seven days of a suspension or deny entry if a caregiver shows symptoms of a serious infectious disease, they cannot block visits for end-of-life care. Additionally, the bill mandates that complaints about denied access to essential caregivers be investigated and resolved within three days.
Older Americans Act Reauthorization Act of 2025 This bill reauthorizes through FY2030, modifies, and establishes programs under the Older Americans Act, which supports social services and activities for individuals aged 60 years or older. Reauthorized programs and activities include the national eldercare locator service; regional aging and disability resource centers; grants to support counseling and assistance on pensions and other retirement benefits; grants to support home-delivered nutrition services (sometimes referred to as meals on wheels programs); programs to facilitate the delivery of supportive services to tribal organizations; and programs to prevent elder abuse, neglect, and exploitation. The bill also modifies existing programs for older individuals, including by explicitly permitting states to use certain grant funds to make carryout meals available at congregate meal sites or community locations. (Some providers began offering carryout meals to seniors in response to the COVID-19 pandemic.) Further, the bill permits the Administration on Aging to establish and operate, through grants to or contracts with eligible entities, a national resource center to support growth of the direct care workforce. The center’s activities may include the provision of training and technical assistance and the promotion of strategies to recruit and retain direct care workers. Finally, the bill establishes or reconvenes certain advisory groups, including (1) an advisory committee to provide guidance regarding the needs of older Native Americans and the implementation of related programs, and (2) a White House Conference on Aging to recommend improvements to federal programs that serve older individuals.
HR 7651, the Chloe Cole Act of 2026, prohibits healthcare providers from performing certain medical interventions on minors under 18 aimed at altering physical development to align with gender identity. These "covered interventions" include puberty blockers, hormone treatments, and specific surgeries, but exclude medically necessary care for conditions like disorders of sexual development or traumatic injuries. The bill creates a federal civil lawsuit right for affected minors or their parents against providers who perform such interventions, allowing claims for damages including emotional distress and punitive awards, with strict liability for providers after the law's enactment. It explicitly allows exceptions for legitimate medical treatments and requires providers to prove such exceptions apply if challenged.
HR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.
HR 6251 would amend the Marine Mammal Protection Act to allow U.S. importation of polar bear trophies (excluding internal organs) from sport hunts in Canada that occurred before specific dates: February 18, 1997, or May 15, 2008. The bill requires hunters to provide proof of legal harvest before those dates and directs the Secretary of the Interior to issue permits without considering current population status or other restrictions under the Act. It directly affects hunters who took polar bears in Canada before these dates and wish to import trophies, bypassing standard MMPA import limitations. The policy change only applies to trophies from past hunts, not future hunting activities.
HR 5880, the "Fight Illicit Pill Presses Act," requires manufacturers and distributors of pill-making machines (like tableting machines) and their critical parts (such as punches and dies) to affix permanent serial numbers to these items. It mandates that these businesses report transactions involving such machines to the Attorney General and maintain records of the serial numbers. The law prohibits tampering with or knowingly distributing machines with removed or altered serial numbers. This directly affects manufacturers, distributors, and sellers of these specific pill-production machines and parts, aiming to improve tracking of equipment used in illicit drug manufacturing.
This bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.
Protecting Privacy in Purchases Act This bill prohibits payment card networks from using merchant codes that distinguish firearms retailers from general-merchandise retailers or sporting-goods retailers. The Department of Justice must enforce this bill and report annually on the resulting investigations and cases.
